Recently, a more effective strategy for the treatment of T2DM has involved the disturbance of dietary monosaccharide absorption by inhibition of α-glucosidase [26], and PTP1B, which is involved in the dephosphorylation and inactivation of the insulin receptor, which attenuates insulin signaling. This evidence concerns the gene INSR and type 2 diabetes mellitus.